01 8Darzalex
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 4,190
2019 Revenue in Millions : 2,998
Growth (%) : 40
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 6,023
2020 Revenue in Millions : 4,190
Growth (%) : 44
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 7,977
2021 Revenue in Millions : 6,023
Growth (%) : 32
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 9,744
2022 Revenue in Millions : 7,977
Growth (%) : 22
Main Therapeutic Indication : Oncology
Currency : USD
2016 Revenue in Millions : 572
2015 Revenue in Millions : 20
Growth (%) : 2,760
Main Therapeutic Indication : Oncology
Currency : USD
2017 Revenue in Millions : 1,242
2016 Revenue in Millions : 572
Growth (%) : 117
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 2,025
2017 Revenue in Millions : 1,242
Growth (%) : 63%
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 2,998
2018 Revenue in Millions : 2,025
Growth (%) : 48
LOOKING FOR A SUPPLIER?
